Natco Pharma gets USFDA approval for Visakhapatnam facility
Hyderabad-based Natco Pharma Ltd on Tuesday said it has received the
final approval from the US health regulator for its first supplemental
abbreviated new drug application (sANDA) filed from its new drug
formulations facility at Visakhapatnam, Andhra Pradesh.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-gets-usfda-approval-for-visakhapatnam-facility/articleshow/75423966.cms
final approval from the US health regulator for its first supplemental
abbreviated new drug application (sANDA) filed from its new drug
formulations facility at Visakhapatnam, Andhra Pradesh.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-gets-usfda-approval-for-visakhapatnam-facility/articleshow/75423966.cms
Comments
Post a Comment